Keli Walbert

Keli Walbert

Director/Board Member at SPRUCE BIOSCIENCES, INC.

Net worth: - $ as of 2026-08-30

59 year
Health Technology
Consumer Services

Profile

Ms. Keli Walbert is an Independent Director at Spruce Biosciences, Inc. She is on the Board of Directors at Hemab Therapeutics Holdings, Inc. and Spruce Biosciences, Inc. Ms. Walbert was previously employed as an Independent Director by Apellis Pharmaceuticals, Inc. and an Executive Vice President-US Commercial by Horizon Therapeutics Ltd. (Ireland).
She received her undergraduate degree from the University of Louisville and a graduate degree from Northwestern University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-20 0 ( -.--% ) - $ 2026-08-30
2026-09-23 0 ( -.--% ) - $ 2026-08-30

Keli Walbert active positions

CompaniesPositionStart
SPRUCE BIOSCIENCES, INC. Director/Board Member 2025-12-10
HEMAB THERAPEUTICS HOLDINGS, INC. Director/Board Member 2026-09-23

Former positions of Keli Walbert

CompaniesPositionEnd
APELLIS PHARMACEUTICALS, INC. Director/Board Member 2026-05-13
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Corporate Officer/Principal 2022-12-31
See the detail of Keli Walbert's experience

Training of Keli Walbert

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

61

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology